← Back to Clinical Trials
Recruiting NCT06773182

NCT06773182 Assessing Interventions of Diet in IBD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06773182
Status Recruiting
Phase
Sponsor McMaster University
Condition IBD (Inflammatory Bowel Disease)
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2025-04-01
Primary Completion 2026-04-01

Trial Parameters

Condition IBD (Inflammatory Bowel Disease)
Sponsor McMaster University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2026-04-01
Interventions
Intermittent Fasting InterventionMediterranean Diet InterventionLow FODMAP Diet Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.

Eligibility Criteria

Inclusion Criteria: * Adults (18+ years) diagnosed with ulcerative colitis or Crohn's disease. * Having willingness to use their personal smartphone to access the app * Able to understand the indication by the registered dietitian. * Able to provide informed consent. * Willingness to attempt intervention diet and commit to study procedures. Exclusion Criteria: * Pregnant women. * Currently being treated for eating disorders, schizophrenia, psychosis, or other acute mental disorders. * Currently being treated for chemotherapy. * Diabetes * Advance chronic kidney disease * Short bowl syndrome

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology